THE ROLE OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY IN ADJUVANT SETTING OF PANCREATIC DUCTAL ADENOCARCINOMA: TUMOR VOLUME AND MICROSATELLITE INSTABILITY INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL